July 14, 2026
Tuesday, July 14, 2026
Today: 8 trending tweets, 8 new studies.
New Research
Safety Profile of Tirzepatide in Real-World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database.
Diabetes, obesity & metabolism
Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation.
Annals of internal medicine
GLP-1 Receptor Agonists and Fertility: What Is Known So Far?
JBRA assisted reproduction
[Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 2].
Revista medica de Chile
Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study.
Obesity pillars
Sustained metabolic control in latent autoimmune diabetes in adults (LADA) with semaglutide therapy in a patient with multiple autoimmune comorbidities: a case report and literature review.
Acta diabetologica
Severe Perioperative Lactic Acidosis and Hyperglycemia Responsive to Thiamine in a Patient With Prior Semaglutide Use and Restrictive Dieting: A Case Report.
A&A practice
Acute Small Bowel Obstruction Induced by Tirzepatide (Mounjaro).
Cureus
Trending on X
The ultimate peptide cheatsheet. Here's every peptide worth knowing, sorted by what it does in your body: Fat loss: → AOD-9604 → 5-Amino-1MQ → Tesofensine → MOTS-c → Setmelanotide → LIPO-C: GLP-1 receptor agonists: → Semaglutide → Tirzepatide → Retatrutide →
🕵️With PCOS (polycystic ovary syndrome) being reclassified as PMOS (polyendocrine metabolic syndrome), thought I’d review the current PCOS and infertility related trials currently recruiting. (Also, a friend was asking!) Many women report meaningful improvements with PCOS
Who the July 23–24 peptide panel is made up of might be the biggest tell we have that the peptide bull market is just getting started. Reuters reported that 7 of the 14 panelists have ties to peptide clinics or peptide therapy businesses. If that’s not a sign that a handful of
We just crossed 2,000 Reptides subscribers, and we're climbing fast. Reptides Briefs is core to what we're building. It's our editorial platform: a free monthly newsletter, plus a paid layer of deeper dives for premium members. We publish full dossiers on single peptides like
We just crossed 2,000 Reptides subscribers, and we're climbing fast. Reptides Briefs is core to what we're building. It's our editorial platform: a free monthly newsletter, plus a paid layer of deeper dives for premium members. We publish full dossiers on single peptides like
Three compounds in the typical peptide conversation are actually FDA-approved drugs semaglutide, tirzepatide, tesamorelin. The rest are not approved. The menu won't tell you which is which.
Here’s a quick breakdown of the key differences between general peptides and Khavinson-style bioregulators: Peptides are short chains of amino acids (typically 2–50). They include hormones (insulin), growth factors (BPC-157, TB-500), signaling molecules (semaglutide), and many
GLP/peptide talk translation: • “Gray market = sold outside authorized prescription/pharmacy channels. • “Research” = labeled “for research—not approved for human use” to enable sale in the US. • GLP-1 = the hormone pathway targeted by this drug class (Sema) • GLP-2 = https://t.co/jw0vVEq3xI
Provider Spotlight
ReadyRX
ReadyRX offers compounded semaglutide — the same active ingredient as Ozempic and Wegovy — with simple monthly pricing, no insurance required. Includes doctor evaluation, overnight delivery, and medication, all 100% online.